Medifast Inc (MED)

Currency in USD
12.97
+0.11(+0.86%)
Closed·
12.970.00(0.00%)
·
Advertisement
MED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.7713.02
52 wk Range
9.2213.63
Key Statistics
Prev. Close
12.86
Open
12.95
Day's Range
12.77-13.02
52 wk Range
9.22-13.63
Volume
67.33K
Average Volume (3m)
121.39K
1-Year Change
13.9719%
Book Value / Share
17.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.00
Downside
-7.48%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Medifast Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 12.00
(-7.48% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stephens
Hold12.00-7.48%15.00Maintain19/02/2026

Medifast Inc Earnings Call Summary for Q3/2026

  • Medifast posted Q3 adjusted loss of $0.19/share vs. $0.62 estimate; revenue of $72M beat forecast by 6.4% despite 19.4% YoY decline.
  • Active coaches fell 47.7% YoY to 10,200, but revenue per coach surged 54.1%, stabilizing sales around $75M for four straight quarters.
  • Launched Trilivy metabolic health platform with 95% coach adoption; targeting Q4 profitability after $17.5M Q3 net loss.
  • Q4 guidance: $55M-$75M revenue, $0-$0.25 adjusted EPS; FY2026: $280M-$300M revenue, $1.80-$2.05 loss/share.
  • Balance sheet holds $172.5M cash with zero debt; Project Catalyst restructuring and AI initiatives expected to improve margins ahead.
Last Updated: 26/10/2026, 13:12
Read Full Transcript

Earnings

Latest Release
26/10/2026
EPS / Forecast
-0.19 / -0.62
Revenue / Forecast
72.05M / 67.7M
EPS Revisions
Last 90 days

Compare MED to Peers and Sector

Metrics to compare
MED
Peers
Sector
Relationship
P/E Ratio
−3.3x−1.4x10.8x
PEG Ratio
0.000.010.03
Price/Book
0.7x1.0x1.5x
Price / LTM Sales
0.5x0.3x0.8x
Upside (Analyst Target)
−7.5%−5.3%22.6%
Fair Value Upside
Unlock29.1%14.0%Unlock

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body’s metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients’ long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body’s metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.95M18.78%25.65M
Other Institutional Investors
6.93M66.64%91.03M
Public Companies & Retail Investors
1.52M14.59%19.93M
Total
10.4M100.00%136.61M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Renaissance Technologies LLC7.48%778,61010,223
Steamboat Capital Partners, LLC7.05%733,3199,628

People Also Watch

77.24
BYD
+0.17%
4.400
GGB
-0.68%
296.52
LAD
-0.22%
66.34
ZION
+0.59%
165.39
HRI
-0.67%

FAQ

What Is the Medifast (NYSE: MED) Share Price Today?

The Medifast stock price today is 12.97 USD.

What Stock Exchange Does Medifast (MED) Trade On?

Medifast is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Medifast?

The stock symbol (also called a 'ticker') for Medifast is "MED."

What Is the Current Medifast Market Capitalisation?

As of today, Medifast (NYSE: MED) market cap is 133.80M USD.

What Is Medifast's (MED) Earnings Per Share (TTM)?

The Medifast EPS is currently -3.69 (Trailing Twelve Months).

When Is the Next Medifast Earnings Date?

Medifast's next earnings report will be released on 23/02/2027.

Is MED a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medifast moving averages and other technical indicators, the daily buy/sell signal for MED stock is Strong Buy.

How Many Times Has Medifast Stock Split?

Medifast has split 0 times. (See the MED stock split history page for full effective split date and price information.)

How Many Employees Does Medifast Have?

Medifast has 380 employees, based on their latest Companies House report.

What is the current trading status of Medifast (NYSE: MED)?

As of 14/11/2026, Medifast (MED) is trading at a share price of 12.97 USD, with a previous close of 12.86 USD. The stock has fluctuated within a day range of 12.77 USD to 13.02 USD, while its 52-week range spans from 9.22 USD to 13.63 USD.

What Is Medifast (MED) Price Target According to Analysts?

The average 12-month price target for Medifast is 12.00 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -7.48% Downside potential.

What Is the MED Premarket Price?

MED's last pre-market stock price is 12.71 USD. The pre-market share volume is 100.00, and the stock has decreased by -0.15, or -1.17%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.